Cure My Disease

Don't miss your cure!

 Log in / Sign up

Real-World data on glofitamab shows promise for Tough-to-Treat lymphoma

NCT ID NCT06994169

Recruiting now Knowledge-focused Sponsor: The Lymphoma Academic Research Organisation Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks back at medical records of about 250 adults with large B-cell lymphoma who received the drug Glofitamab through a special access program in France. The goal is to see how well the drug works and what side effects occur in everyday practice, especially in patients whose cancer came back after CAR-T cell therapy. Researchers will track tumor shrinkage and survival over at least 9 months.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LARGE B-CELL LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

large B-cell lymphoma relapsed/refractory diffuse large B-cell lymphoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LARGE B-CELL LYMPHOMA

Contacts and locations

Locations

  • CH Victor Dupouy

    RECRUITING

    Argenteuil, 95100, France

  • CH d'Avignon - Hôpital Henri Dufaut

    RECRUITING

    Avignon, 84000, France

  • CH de Dunkerque

    RECRUITING

    Dunkirk, France

  • CH de Mulhouse Sud Alsace

    RECRUITING

    Mulhouse, 68070, France

  • CH de Quimper Cornouaille

    RECRUITING

    Quimper, 29107, France

  • CH de la Côte Basque

    RECRUITING

    Bayonne, France

  • CHR d'Orléans

    RECRUITING

    Orléans, France

  • CHRU Besançon - Hôpital Minjoz

    RECRUITING

    Besançon, France

  • CHRU de LILLE - Claude Huriez

    RECRUITING

    Lille, France

  • CHRU de Nancy - Hôpital de Brabois

    RECRUITING

    Vandœuvre-lès-Nancy, France

  • CHU Lyon Sud

    RECRUITING

    Pierre-Bénite, France

  • CHU de Dijon - Hôpital le Bocage

    RECRUITING

    Dijon, 21000, France

  • CHU de Grenoble - Hôpital Albert Michallon

    RECRUITING

    La Tronche, France

  • CHU de Poitiers - Hôpital de La Milétrie

    RECRUITING

    Poitiers, France

  • CHU de Rennes - Hôpital de Pontchaillou

    RECRUITING

    Rennes, France

  • CHU de Strasbourg

    RECRUITING

    Strasbourg, France

  • Centre Léon Bérard

    RECRUITING

    Lyon, 69373, France

  • Ch de Bretagne Atlantique

    RECRUITING

    Vannes, France

  • Chu Bretonneau

    RECRUITING

    Tours, France

  • Chu de Bordeaux - Hopital Haut-Leveque

    RECRUITING

    Pessac, France

  • Clinique du Pont de Chaume

    RECRUITING

    Montauban, France

  • Gustave Roussy Cancer Campus Grand Paris

    RECRUITING

    Villejuif, France

  • Hopital D'Instruction Des Armees Percy

    RECRUITING

    Clamart, 92141, France

  • Hopital Henri Mondor

    RECRUITING

    Créteil, France

  • Hopital Saint Vincent-de-Paul

    RECRUITING

    Lille, France

  • Hopital Saint-Louis

    RECRUITING

    Paris, France

  • Hôpital de Libourne

    RECRUITING

    Libourne, France

  • INSTITUT PAOLI CALMETTES - Service Hématologie

    RECRUITING

    Marseille, France

  • Institut Curie - Site Saint-Cloud

    RECRUITING

    Saint-Cloud, France

  • Institut Universitaire du Cancer de Toulouse - Oncopole

    RECRUITING

    Toulouse, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.